MedChunk
Medically reviewed

AMH Levels and IVF: Causes, Symptoms, and Treatment

Learn what low and high AMH levels mean for IVF, their possible causes, associated symptoms, and how fertility specialists adjust treatment based on ovarian reserve.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 14 min read

AMH is a blood test that helps estimate how many eggs may be available in the ovaries and how they might respond to IVF medicines. Low or high AMH levels can help fertility specialists plan treatment, but they cannot determine egg quality or predict with certainty whether someone will become pregnant.

What does AMH tell you about IVF?

Anti-Müllerian hormone (AMH) is produced by small developing follicles in the ovaries. These follicles are tiny fluid-filled sacs that contain immature eggs. The amount of AMH in the blood gives an estimate of the number of small follicles present, which is used as a marker of ovarian reserve.

Ovarian reserve refers to the remaining supply of eggs in the ovaries. It naturally decreases with age. During IVF, doctors use AMH results to estimate how many eggs the ovaries might produce after fertility medicines stimulate them.

According to the National Library of Medicine's MedlinePlus, AMH testing can help fertility specialists estimate ovarian reserve and decide how much fertility medicine may be needed during IVF. However, it cannot measure the health of the eggs or establish whether pregnancy will occur.

This distinction is important because IVF involves more than retrieving eggs. The eggs must mature, fertilize, develop into embryos, and have the potential to result in a pregnancy. AMH mainly helps predict the number of eggs that may be retrieved, rather than the final outcome.

What do low, normal, and high AMH levels mean?

AMH results are interpreted according to age, laboratory methods, and the reason for testing. There is no single AMH value that guarantees a successful IVF cycle or applies equally to everyone.

Some laboratories report AMH in nanograms per milliliter (ng/mL), while others use picomoles per liter (pmol/L). Reference ranges can differ between laboratories, so results should be compared with the range provided by the testing laboratory and interpreted by a fertility specialist.

Low AMH levels

A low AMH result may indicate a smaller number of developing follicles and a reduced ovarian reserve. During IVF, this can mean that the ovaries produce fewer eggs in response to stimulation medicines than expected.

Possible implications of low AMH include:

  • Fewer eggs may develop during an IVF stimulation cycle.
  • A lower number of eggs may be available for retrieval.
  • Fewer mature eggs may be available for fertilization.
  • There may be fewer embryos available for transfer or freezing.
  • More than one treatment cycle may be discussed, depending on the overall fertility assessment and treatment goals.

However, low AMH does not mean that pregnancy is impossible. Some people with low AMH respond to IVF medicines and produce eggs that can develop into embryos. The actual response depends on several factors, particularly age and individual ovarian function.

Normal or age-appropriate AMH levels

An AMH result within the laboratory's expected range for a person's age may suggest an ovarian reserve that is broadly consistent with that reference range. It can also help the fertility specialist estimate the likely response to ovarian stimulation.

However, a normal AMH result does not guarantee a successful IVF cycle. Other factors, such as age, egg quality, sperm quality, embryo development, and the condition of the uterus, also influence pregnancy outcomes.

High AMH levels

High AMH levels may indicate that the ovaries contain a relatively large number of small follicles. This can be associated with a stronger response to fertility medicines during IVF.

High AMH is sometimes associated with polycystic ovary syndrome (PCOS), a hormonal condition that can affect ovulation. However, an elevated AMH result alone does not establish a PCOS diagnosis.

Another important consideration is ovarian hyperstimulation syndrome (OHSS). This is a complication in which the ovaries respond excessively to fertility medicines. People with elevated AMH, PCOS, or an expected high egg yield may have a greater risk of OHSS during fertility treatment.

What causes AMH levels to be low or high?

AMH levels mainly reflect the number of small developing follicles in the ovaries. Several age-related, genetic, medical, and hormonal factors can influence the result.

Factors associated with low AMH

  • Increasing age: The number of eggs in the ovaries naturally decreases over time. AMH levels generally decline as ovarian reserve reduces with age.
  • Genetic factors: Certain genetic conditions, including an FMR1 gene premutation, may be associated with diminished ovarian reserve.
  • Chemotherapy or radiation exposure: Some cancer treatments can affect ovarian function and reduce the available egg supply.
  • Hormonal contraception: Current or recent use of combined oral contraceptive pills may lower measured AMH levels in some people. This can affect how the result is interpreted.

The American Society for Reproductive Medicine (ASRM) identifies age as the most important predictor of female reproductive potential and recommends interpreting ovarian reserve results alongside medical history, risk factors, and previous treatment responses.

Factors associated with high AMH

  • PCOS: Some people with PCOS have a larger number of small ovarian follicles and higher AMH levels.
  • Higher follicle numbers: A larger group of developing follicles can produce more AMH. This may also be associated with a stronger response to IVF stimulation.
  • Age: AMH levels change throughout reproductive life. They generally peak in early adulthood and decline as a person gets older.

The ASRM's international PCOS guideline explains that AMH can be used as part of the assessment of ovarian appearance in adults, but it should not be used as the only test to diagnose PCOS. Age, body mass index, hormonal contraception, and other factors may also influence AMH measurements.

Does low or high AMH cause symptoms?

AMH itself does not usually cause noticeable symptoms. A person may have low AMH without experiencing any clear physical changes. Similarly, high AMH does not necessarily cause symptoms.

Low AMH is often discovered during fertility testing rather than through physical symptoms. Some people may seek an assessment because they have difficulty becoming pregnant, but this does not mean that low AMH is the only possible explanation.

When high AMH is associated with PCOS, symptoms may relate to the underlying hormonal condition rather than the AMH level itself. These can include:

  • Irregular or infrequent menstrual periods.
  • Signs of increased androgen activity, such as unwanted facial or body hair.
  • Acne or other skin changes associated with hormonal imbalance.
  • Difficulty ovulating regularly, which may affect the ability to conceive.

Not everyone with PCOS experiences the same features, and an elevated AMH result alone is not enough to explain menstrual changes or establish the underlying cause. A fertility or gynecology assessment may include menstrual history, hormone testing, and ultrasound findings.

How are AMH levels checked before IVF?

AMH is measured through a blood test. A healthcare professional takes a blood sample, which is sent to a laboratory for analysis. Unlike some other reproductive hormones, AMH can generally be measured at any point in the menstrual cycle.

Fertility specialists often combine AMH testing with other assessments to understand ovarian reserve and plan IVF treatment.

Other tests used with AMH

Antral follicle count (AFC): A transvaginal ultrasound is used to count small follicles in both ovaries. This gives the specialist an additional estimate of ovarian reserve and helps predict the response to stimulation medicines.

Follicle-stimulating hormone (FSH): This hormone helps stimulate follicle development. Blood testing is generally performed early in the menstrual cycle, usually on days 2 to 4. Higher-than-expected FSH levels may provide additional information about reduced ovarian reserve.

Estradiol: This hormone is often measured with FSH during the early part of the menstrual cycle. It can help the fertility specialist interpret the FSH result.

According to the ASRM's 2026 fertility evaluation guidance, AMH, antral follicle count, and basal FSH with estradiol are among the tests used to assess ovarian reserve. AMH can be measured at any point in the cycle, while basal FSH and estradiol are measured together early in the menstrual cycle.

How do AMH levels affect IVF treatment?

AMH results help fertility specialists choose an ovarian stimulation approach. The aim is to encourage the ovaries to develop an appropriate number of mature eggs while reducing the risk of complications.

IVF treatment when AMH is low

When AMH is low, the fertility specialist may adjust the stimulation plan to account for the possibility of a lower egg yield. Treatment decisions are based on the person's age, AMH level, AFC, previous IVF response, and other reproductive findings.

Possible treatment considerations include:

  • Individualized medicine doses: The specialist may adjust fertility medicine doses according to the expected ovarian response.
  • Monitoring during stimulation: Ultrasound scans and hormone tests help track follicle growth and guide treatment decisions.
  • Realistic expectations: The specialist discusses the possibility of retrieving fewer eggs and how this may affect embryo development and transfer opportunities.
  • Reviewing future cycles: If the response is lower than expected, the treatment plan may be reviewed before another cycle.

Low AMH does not automatically mean that IVF will fail. Even when ovarian reserve is limited, eggs may still develop and result in embryos. The suitability of treatment should be based on the complete clinical picture rather than one test result.

The ASRM committee opinion on ovarian reserve testing states that AMH and AFC are useful for predicting egg numbers and ovarian response during IVF, but have a weak relationship with egg quality, clinical pregnancy, and live birth. It also advises against refusing IVF solely because AMH is extremely low.

IVF treatment when AMH is high

High AMH may indicate that the ovaries could respond strongly to stimulation medicines. Although this may result in more eggs being available for retrieval, it also means that the fertility team needs to consider the risk of excessive ovarian stimulation.

Depending on the individual assessment, treatment adjustments may include:

  • Lower starting medicine doses: The specialist may use a lower dose of stimulation medicine when a strong response is expected.
  • Individualized stimulation protocols: The choice of medicines and treatment schedule may be adjusted to reduce the chance of excessive ovarian response.
  • Closer monitoring: Ultrasound examinations and hormone measurements help identify how the ovaries are responding.
  • OHSS prevention strategies: The fertility team may choose an appropriate trigger medicine or embryo-freezing approach when needed to reduce the risk of complications.

The ASRM guideline on preventing ovarian hyperstimulation syndrome recommends identifying people with elevated AMH, PCOS, or an expected high egg yield as potentially having an increased risk of OHSS. It supports individualized medicine dosing and appropriate stimulation protocols to help reduce this risk.

Can low AMH be improved before IVF?

AMH is a marker of ovarian reserve, not a measurement that can be treated in the same way as a hormone deficiency. Raising the AMH number does not necessarily increase the number of eggs available or improve the chance of a successful pregnancy.

There is no established treatment that reliably restores the natural egg supply or reverses age-related loss of ovarian reserve. Fertility specialists generally focus on understanding the cause of a low result, assessing the likely ovarian response, and planning treatment around the available follicles.

People considering supplements, hormone products, or other treatments marketed to increase AMH should discuss them with a fertility specialist before use. An increase in a laboratory measurement should not be assumed to mean that IVF outcomes will improve.

Does AMH predict IVF success?

AMH is useful for estimating how many eggs may be retrieved during IVF, but it is not a reliable standalone predictor of pregnancy or live birth.

Age is especially important because it influences reproductive potential and the likelihood of obtaining eggs capable of developing into healthy embryos. For example, two people with similar AMH results may have different IVF outcomes because they are different ages or have different reproductive and medical histories.

Other factors considered during treatment include:

  • Age and overall reproductive health.
  • Previous response to ovarian stimulation.
  • Egg maturity and fertilization results.
  • Sperm quality and other male fertility factors.
  • Embryo development and quality.
  • Uterine health and other factors affecting embryo transfer and pregnancy.

For this reason, AMH should be used as one part of IVF planning rather than as a final judgment about fertility or the likelihood of having a baby.

When should you discuss your AMH result with a fertility specialist?

A fertility consultation can help explain what an AMH result means for a person's age and treatment plans. It is particularly useful when:

  • AMH is lower or higher than the laboratory's expected range.
  • IVF or egg freezing is being considered.
  • There is a history of chemotherapy, radiation exposure, or a genetic condition associated with reduced ovarian reserve.
  • Menstrual periods are irregular or there are other features suggesting a hormonal condition such as PCOS.
  • A previous IVF cycle produced fewer or more eggs than expected.

During the consultation, useful questions include what the AMH result suggests about the expected egg yield, how age affects the treatment outlook, whether additional testing is needed, and what can be done to reduce the risk of ovarian hyperstimulation.

Understanding AMH in context can make IVF planning more practical and informed. A low result does not automatically rule out treatment, while a high result does not guarantee pregnancy. The most useful approach is an individualized plan based on ovarian reserve, age, medical history, and the expected response to fertility medicines.

Frequently Asked Questions

Common questions about AMH results, ovarian reserve, and IVF treatment.

Can IVF be successful with very low AMH?

Yes. Very low AMH may mean that fewer eggs are available during IVF, but it does not make pregnancy impossible. Some people with very low AMH still produce eggs that can fertilize and develop into embryos. Age, overall reproductive health, and individual treatment response are important when discussing the chances of success.

Is high AMH always better for IVF?

No. High AMH may indicate more small ovarian follicles and a stronger response to stimulation medicines. However, it may also increase the risk of ovarian hyperstimulation syndrome. A fertility specialist may adjust the medicine dose and treatment protocol to manage this risk.

Does low AMH mean poor egg quality?

No. AMH mainly estimates ovarian reserve and helps predict the number of eggs that may respond to fertility medicines. It does not directly measure egg quality. Age and other reproductive factors are important when assessing the likelihood of pregnancy after IVF.

Can AMH levels change between IVF cycles?

AMH is generally more stable across menstrual cycles than some other reproductive hormones, but results can be influenced by factors such as hormonal contraception and laboratory methods. A person's AMH may also change over time as ovarian reserve declines with age. Fertility specialists interpret results alongside previous tests and treatment responses.

Should IVF be avoided when AMH is very low?

Not necessarily. A very low AMH result may indicate a lower expected egg yield, but it should not be the only reason to refuse IVF. A fertility specialist can explain the likely response, discuss treatment limitations, and consider the person's age, medical history, and reproductive goals.

Citations

  1. National Library of Medicine – MedlinePlus: Anti-Müllerian Hormone Test
  2. American Society for Reproductive Medicine – Fertility Evaluation of Infertile Women: A Committee Opinion (2026)
  3. American Society for Reproductive Medicine – Testing and Interpreting Measures of Ovarian Reserve (2020)
  4. American Society for Reproductive Medicine – Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
  5. American Society for Reproductive Medicine – Prevention of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline (2023)
Share this article